Shots:

• The US FDA has approved cobas HIV-1/HIV-2 Qualitative Test for use on the fully automated cobas 6800/8800 Systems in the US. The test combines the confirmatory HIV testing and HIV-1/HIV-2 differentiation into one single test to identify appropriate treatment options
• The higher sensitivity of PCR technology is used in the cobas HIV-1/HIV-2 Qualitative Test that can reduce the time-to-detection period by 1 week or more. The test provides clinicians critical diagnostic data for personalized treatment of patients with HIV
• cobas HIV-1/HIV-2 Qualitative test is an in vitro nucleic acid amplification test for the qualitative detection and differentiation of HIV-1 and HIV-2 RNA in human serum and plasma

­ Ref: Roche | Image: Roche